Response to: Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’
Vox Sanguinis · 2026-11 · 121 (11) · 1779-1780
DOI: 10.1111/vox.70323 ↗Kurz gefasst
Leserbrief in der Zeitschrift Vox Sanguinis, online erschienen am 08.09.2026. Verfasst von Monica Chaves und 2 weiteren Autor:innen. Beteiligte Einrichtung: Roche Diagnostics International, Rotkreuz, Switzerland. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Roche Diagnostics International, Rotkreuz, Switzerland.
- Roche Diagnostics GmbH, Penzberg, Germany.
ORCID-Profile: Florina Pessl
Zitieren
APA
Chaves, M., Schaetzl, M., & Pessl, F. (2026). Response to: Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’. Vox Sanguinis, 121(11), 1779-1780. https://doi.org/10.1111/vox.70323
Vancouver
Chaves M, Schaetzl M, Pessl F. Response to: Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’. Vox Sanguinis. 2026;121(11):1779-1780. doi:10.1111/vox.70323
BibTeX
@article{Chaves2026,
author = {Chaves, Monica and Schaetzl, Martina and Pessl, Florina},
title = {Response to: Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’},
journal = {Vox Sanguinis},
year = {2026},
volume = {121},
number = {11},
pages = {1779--1780},
doi = {10.1111/vox.70323}
}
EUVIMED